Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Commitment to partnership and joint innovation for cell and gene therapies
Executiva, 23 February 2026
C&EN, November 12, 2018
Irish Examiner, 21 june 2021
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Hovione commitment to setting SBTs in line with the Paris Agreement
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction